A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments

Shengde Wu(Procter & Gamble (United States)), Karen Blackburn(Procter & Gamble (United States)), Jack Amburgey(Procter & Gamble (United States)), Joanna Jaworska(Procter & Gamble (Belgium)), Thomas W. Federle(Procter & Gamble (United States))
Regulatory Toxicology and Pharmacology
September 20, 2009
Cited by 165

Abstract


Related Papers

No related papers found

Powered by citation graph analysis